Aidoc

Aidoc is a pioneering healthcare AI company that specializes in clinical workflow optimization and triage. Founded in 2016, the company provides an enterprise-grade platform known as aiOS, which integrates seamlessly with hospital PACS and EHR systems to analyze medical imaging in real-time. By utilizing its proprietary CARE foundation model, Aidoc enables healthcare providers to identify time-sensitive pathologies, such as intracranial hemorrhages and pulmonary embolisms, thereby reducing diagnostic delays and improving patient outcomes.

Aidoc’s mission is to transform patient outcomes through 'always on' clinical AI, eliminating preventable care gaps that lead to loss of lives and disabilities.

• Holds over 18 FDA-cleared AI indications for medical imaging.
• Deployed in over 1,600 hospitals worldwide, supporting 45 million patients annually.
• Achieved unicorn status in 2025 with a valuation exceeding $1 billion.
• Received FDA Breakthrough Device Designation for a multi-triage solution in 2025.
• Secured $150 million in Series E funding led by Goldman Sachs Alternatives in 2026.

Sources

• Official Aidoc Website
• Industry News and Funding Reports